Pschopharmacology Flashcards
Classification of treatments
- Chemical
- e.g. drugs, medicines, immunotherapy
- Electrical stimulation
- e.g. ECT, neurostimulation
- Structural rearrangement
- e.g. surgery, deep brain stimulation, psychosurgery
- Talking (psycho) therapies
- e.g. CBT, exposure therapy
Classification of psychiatric drugs
Based on chemical structure
- Every drug has unique structure
- Not useful for clinical decision making, more for data and synthesis
Based on what illnesses they treat
- Easy for doctors to choose a drug based on diagnosis
- Some drugs may work in different disorders
- Many psychiatric disorders have multiple symptoms, and one medicine may not treat them all
Based on pharmacology
- E.g. instead of antipsychotic, dopamine blocker
- E.g. instead of antidepressant, serotonin / noradrenaline / dopamine enhancer
- E.g. instead of hypnotic or anxiolytic, GABA enhancer
GABA receptors
GABA-A - ion channel which spans nerve membrane
- benzodiazepines, alcohol, anaesthetics, and barbiturates enhance GABA
Is the major inhibitory neurotransmitter in the cns so when activated it conducts cl- causing hyperpolarization
GABA-B - G protein coupled receptor
- GHB binds with a low affinity via GIRK CHANNELS,when activated causes k+ extrusion so hyperpoloarization. Weak agonist propoerty of GHK seen centrally only not in spinal chord as has no affinity there for BDZ or alcohol
Chemical treatments in psychiatry
Work on one (occasionally two) of the following systems:
- Receptors
- Neurotransmitter reuptakes sites
- Ion channels
- Enzymes
Targets are in the brain, but can affect systems elsewhere in the body - particularly in the liver if the target is an enzyme
Most neurotransmitters reuptaken into neurones via transporters, some limit further release of neurotransmitter, some broken down enzymatically.
Enzyme targeting medicines
- Monoamine oxidase Inhibitors for treatment of depression and anxiety
- Acetylcholinesterase inhibitors for dementia
- Lithium as a mood stabiliser (blocks glycogen synthase kinase, to prevent cyclical dysregulation seen in bipolar disorder)
Receptor targeting medicines
- Receptor blockers (antagonists)
- Dopamine receptor blockers for schizophrenia
- Serotonin receptor subtype blockers for depression
- Histamine receptor blockers for sleep
Antagonists block endogenous agonist binding to the receptor - Receptor stimulators (agonists)
- Benzodiazepines for sleep (enhances GABA)
- Guanfacine for ADHD (enhances noradrenaline)
Agonists mimic the endogenous agonist, stimulating the receptor
Reuptake site targeting medicines
- Citalopram (serotonin reuptake inhibitor - SRI) for depression and anxiety
- Desipramine (noradrenaline reuptake inhibitor - NRI) for depression
- Methylphenidate (dopamine reuptake inhibitor - DRI) for ADHD
- Some medicines switch the reuptake site direction to enhance release of neurotransmitters
- e.g. amfetamine for ADHD (releases dopamine and noradrenaline, and blocks reuptake)
Seratonin neurotransmitter system 5-HT
- 5HT neurones begin in the midbrain, and extend to the hippocampus
- Serotonin is released, which then works on serotonin receptors on the post synapse
- There are 15 separate genes which encode for serotonin receptors, which control a variety of functions, including:
- Cognition
- Mood
- Temperature control
- Carbon dioxide regulation
Some, such as 5HT1a, are inhibitory, but most are excitatory.
The coupling to G proteins or ion channels determine if inhibitory or excitatory - Serotonin is reuptaken at reuptake channels in the synaptic and axon membrane
- This process is blocked by SRIs
- Serotonin may also act on presynaptic receptors to inhibit neurone firing and further serotonin release - homeostatic regulation
Ion channel targeting medicines:
blocks channels to reduce neuronal excitability)
- Sodium channel blockers
- Sodium valproate for epilepsy and to stabilise mood
- Carbamazepine for epilepsy and to stabilise mood
- Calcium channel blockers
- Gabapentin for epilepsy and anxiety
- Pregabalin for epilepsy and anxiety
Fast acting Neurotransmitters (on-off switch)
- Excitatory ⇒ glutamate, 80% of all neurons in pyramidal cells
- Inhibitory ⇒ GABA, 15% of interneurones
- Roles in core processes involved with memory, movement, vision etc
Slow acting Neurotransmitters (modulators)
- Dopamine, serotonin, noradrenaline, acetylcholine
- Endorphins and other peptides
- Roles in emotions, drives and motivations, attention, and valence of memories
Glutamate
- Causes epilepsy when in excess, may be treated with the blocker Perampanel
- Found in high levels in alcoholism, may be treated with the blockers Acamprosate or Ketamine
GABA
Causes anxiety when deficient may be treated with enhancer benzodiazepines
5-HT
Deficiency of 5-HT results in Depression or anxiety, which may be treated with serotonin enhancers such as SRIs or MAOIs
Dopamine
Excess dopamine is associated with psychosis, which may be treated with dopamine receptor blockers.
The idea for using these blockers as a treatment for dopamine came from amfetamine psychosis amongst cyclists